Hepatitis

  • Most Topular Stories

  • Project pilots a new way to deal with 'silent killer' hepatitis C

    Hepatitis News
    18 Aug 2014 | 11:09 pm
    The Addaction Cornwall hepatitis C pilot programme team pictured with Charles Gore from the Hepatitis C Trust and Dr Hyder Hussaini from the Royal Cornwall Hospital.
  • Pork Consumption and Seroprevalence of Hepatitis E Virus,Thailand, 2007 - "2008

    Hepatitis News
    19 Aug 2014 | 9:08 am
    The nationwide seroprevalence of hepatitis E IgG was determined among young men in Thailand.
  • New Study: A Place for Milk Thistle in Hepatitis C Treatment

    Hepatitis Central
    Nicole Cutler L.Ac.
    1 Aug 2014 | 9:31 am
    Ever since the newer, direct-acting antiviral drugs were FDA-approved in the Spring of 2011, triple therapy has significantly improved the odds of successfully eliminating the Hepatitis C virus. Despite this therapeutic improvement, individuals co-infected with HIV (the virus that causes AIDS) and Hepatitis C are among the most likely to fail treatment. Researchers in Switzerland have found that administering a potent form of milk thistle prior to beginning triple therapy dramatically improves patient outcome. HIV/Hepatitis C Co-Infection According to the U.S. Department of Disease Control…
  • New drug spurs liver regeneration after surgery

    Liver Disease / Hepatitis News From Medical News Today
    13 Aug 2014 | 1:00 am
    A new drug spurs liver regeneration after surgery, according to a paper published in The Journal of Experimental Medicine.
  • Identification of an MLL4‐GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child

    MedWorm: Hepatitis B
    19 Aug 2014 | 7:03 am
    Undifferentiated spindle cell sarcoma (UDS) is a poorly defined or understood entity, essentially a waste‐basket for cases failing to fulfill criteria for better‐established diagnoses based on combined histology, immunohistochemistry, and tumor genetic assays. We identified a novel chromosomal translocation t(17;19)(p13;q13) in a pediatric UDS and have characterized this alteration to show rearrangement of the MLL4 and GPS2 genes, resulting in an in‐frame fusion gene MLL4‐GPS2, the expression of which promotes anchorage‐independent growth. MLL4 was previously reported to be…
 
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • Tour the Digestive System

    hepatitis.guide@about.com
    19 Aug 2014 | 4:10 am
    The organs of the digestive system work together to digest and absorb food. Let's look at each organ and learn what it does.
  • The 4 Most Common Symptoms of Hepatitis

    hepatitis.guide@about.com
    19 Aug 2014 | 4:10 am
    Most diseases have their classic symptoms and hepatitis is no exception. Here is a list of symptoms and their descriptions that are frequently seen with hepatitis. Remember, though, that some people with the disease will not have any of these problems.
  • Information about Milk Thistle

    hepatitis.guide@about.com
    19 Aug 2014 | 4:10 am
    Milk thistle is popular for treating chronic hepatitis. Here are answers to the most asked questions about what milk thistle is and how it works.
  • Is Hepatitis B Spread Through Sex?

    hepatitis.guide@about.com
    19 Aug 2014 | 4:10 am
    Learn about how the Hepatitis B virus spreads, how to prevent your infection, and what other ways you can get infected with HBV.
  • What Are the Common Tests That Help Diagnose...

    hepatitis.guide@about.com
    19 Aug 2014 | 4:10 am
    Doctors use several methods to help diagnose hepatitis. These include blood tests for enzymes and antibodies and more advanced testing like biopsy and magnetic resonance imaging.
  • add this feed to my.Alltop

    About.com Hepatitis: Most Popular Articles

  • Four Natural Remedies That Won't Cure Hepatitis

    19 Aug 2014 | 5:19 am
    Even though herbs, dietary supplements and homeopathic remedies don't require a prescription and are available in most health food stores, people should be cautious and suspicious of their value. Here are four natural treatments that people take to treat various forms of viral hepatitis. Unfortunately, there is no real evidence that they work.
  • Hepatocyte

    19 Aug 2014 | 5:19 am
    Definition of Hepatocyte. Hepatitis.
  • What It Means if Your Doctor Orders an HBsAG Test

    19 Aug 2014 | 5:19 am
    Definition of HBsAG. Hepatitis.
  • Virus

    19 Aug 2014 | 5:19 am
    Definition of virus. Hepatitis.
  • How Healthy Is Your Liver?

    19 Aug 2014 | 5:19 am
    Liver enzymes allow doctors to learn about the health of your liver. There are thousands of these enzymes in the liver and blood stream, but two of them--two aminotransferases--are especially useful for determining liver disease: AST and ALT.
 
  • add this feed to my.Alltop

    Hepatitis Central

  • Incivek (Telaprevir) Will No Longer be Available for Hepatitis C Patients

    The Editors at Hepatitis Central
    15 Aug 2014 | 9:38 am
    Vertex to stop selling hepatitis C drug Incivek In a move that shows how fast things can change in the biotechnology industry, Vertex Pharmaceuticals Inc. has told doctors it will discontinue sales of Incivek, the hepatitis C treatment that was the first drug developed by the Boston company. Continue reading this entire article: http://www.bostonglobe.com/business/2014/08/12/vertex-stop-selling-hepatitis-drug-incivek/El0jtOpH9I1CaIgQpSUKWO/story.html  
  • After Being Cured…Can Hep C Return?

    Nicole Cutler L.Ac.
    14 Aug 2014 | 9:00 am
    Treatment regimes for Hepatitis C have been steadily improving, leaving a growing number of people with a well-earned, congratulatory status of beating the virus. Instead of ‘beating the virus,’ some health professionals use the word cure to describe successful Hepatitis C treatment. Regardless of what you call this coveted achievement, those who have been cured of Hepatitis C are often dubious of its permanence. Sustained Virologic Response The benchmark of Hepatitis C treatment, a sustained virologic response (SVR) is as close as we can get to a cure for this disease. SVR is declared if…
  • New Research Finds Pomegranates Help Battle Hepatitis C

    Nicole Cutler L.Ac.
    5 Aug 2014 | 6:36 am
    Hepatitis C is a tenacious, sneaky virus that may be rendered a bit less tenacious and sneaky by pomegranate. For the estimated four million Americans with Hepatitis C, improvements in medication cocktails have improved the odds of being cured of Hepatitis C. However, thousands of individuals must manage this potentially lethal illness on their own. Evidence has been mounting of pomegranate’s value to heart and liver health, but a new study demonstrates this fruit’s specific capability to inhibit the Hepatitis C virus. Hepatitis C is Tenacious and Sneaky First discovered as a new virus…
  • New Study: A Place for Milk Thistle in Hepatitis C Treatment

    Nicole Cutler L.Ac.
    1 Aug 2014 | 9:31 am
    Ever since the newer, direct-acting antiviral drugs were FDA-approved in the Spring of 2011, triple therapy has significantly improved the odds of successfully eliminating the Hepatitis C virus. Despite this therapeutic improvement, individuals co-infected with HIV (the virus that causes AIDS) and Hepatitis C are among the most likely to fail treatment. Researchers in Switzerland have found that administering a potent form of milk thistle prior to beginning triple therapy dramatically improves patient outcome. HIV/Hepatitis C Co-Infection According to the U.S. Department of Disease Control…
  • Meet the HCV Expert

    The Editors at Hepatitis Central
    23 Jul 2014 | 6:45 am
    A Discussion on HCV and What You Need to Know Join patients, caregivers and support care personnel in this “Meet the HCV Expert” webinar featuring Aijaz Ahmed, MD of the University of Stanford on Monday, July 28, 2014 at 7pm Pacific Time. Dr. Ahmed is an Associate Professor of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine in Stanford, CA. His clinical focus is in hepatology, gastroenterology and liver transplantation. Register for this event at http://www.meetthehcvexpert.com/Ahmed/registration.cfm.
 
  • add this feed to my.Alltop

    Hepatitis C Treatment News

  • $1,000 Sovaldi now hepatitis treatment of choice

    20 Aug 2014 | 12:17 am
    … prescriptions for all hepatitis C pills has soared, highlighting … for four such medications, with Sovaldi … hepatitis C. In 2011 filings with federal regulators, the company that originally developed … bargain. The older hepatitis C treatments take longer and …
  • The Medical Innovation Threat

    19 Aug 2014 | 9:36 pm
    … permanent damage to the development of specialty drugs. The relentless assault on … a near-perfect cure rate for Hepatitis C, the liver-destroying virus that infects …
  • What's happening Wednesday in the north valley

    19 Aug 2014 | 3:58 pm
    … : 6:30-7:45 a.m. Develop communication skills. Cozy Dinner, 6371 … Rio Lindo Ave. Wellness, 879-3311; Med Clinic, 879-3974. Weekly. Stroke Support … , 1528 Esplanade. 332-3981. Third Wednesday. Hepatitis C support and class, Oroville: 2-3 …
  • Why Achillion Pharmaceuticals (ACHN) Stock Is Up in After-Hours Trading Today

    19 Aug 2014 | 2:46 pm
    … received a patent for its hepatitis C drug ACH-3102. The U.S … being investigated as a treatment for chronic hepatitis C virus (HCV) infection. Must … 2 trials evaluating their use in all-oral combination regimens for the treatment …
  • Sanofi Wins U.S. Approval for Pill to Treat Rare Gaucher Disease

    19 Aug 2014 | 2:30 pm
    … FDA, reflecting the agency’s focus and commitment to the development of treatments … on Gilead Sciences Inc.’s hepatitis C pill Sovaldi has raised the ire … compare the drugs’ effectiveness. “There’s some evidence this treatment may be …
  • add this feed to my.Alltop

    Today

  • In defense of fanny packs, and Matthew McConaughey's style

    Kurt Schlosser
    19 Aug 2014 | 2:49 pm
    Fanny packs have been the butt of too many jokes, and it's no longer alright. Alright? Alright. Matthew McConaughey, we've got your back in defense of the much-maligned fashion accessory.The Oscar-winning actor was interviewed in the stands at Fenway Park on Sunday during the Red Sox game against the visiting Houston Astros.
  • 7 things to know before getting a manicure

    Kate Anderson
    19 Aug 2014 | 1:00 pm
    Getting a manicure might seem like perfect excuse to just sit back and relax, but it turns out there are some pretty ugly dangers lurking inside the salon. Sephora nail and gel expert Terri Silacci tells you what to watch out for.Cutting cuticles can cause permanent damageEver notice that some people have wavy nail beds? This permanent condition can sometimes be caused by over-clipping cuticles.
  • Man tracks down family who left home videos of newborn baby in Goodwill camera

    Kerry Wills
    19 Aug 2014 | 12:48 pm
    A perfect storm of old-fashioned sentimentality and new media fervor created a little miracle this week.A Kentucky dad who bought an old video camera at a thrift store was just planning to revisit his own family’s memories, using the outdated gadget to play his old videotapes.
  • 3 easy stretches you should do every night

    Jenna Wolfe
    19 Aug 2014 | 12:36 pm
    Consider this: If you’re like most people you spend a good part of your day slumped over a computer. This tightens up muscles like your hip flexors (those muscles in front of your thighs) and creates rounded shoulders and a shrunken chest. Before you know it your back hurts, your shoulder aches and you feel as if you’ve aged 10 years.
  • 'Breaking Bad' stars reunite in reality spoof with Julia Louis-Dreyfus

    Kurt Schlosser
    19 Aug 2014 | 11:52 am
    Bryan Cranston and Aaron Paul have ditched the meth business for the pawn business, and Julia Louis-Dreyfus is a long way from the White House in a fun new spoof video ahead of the upcoming Emmy Awards.
 
  • add this feed to my.Alltop

    HCV New Drug Research

  • Hepatitis C - 40% Surveyed Specialists Expect to Prescribe Gilead's Sofosbuvir/Ledipasvir Regimen

    19 Aug 2014 | 7:47 am
    Nearly Half of Surveyed Specialists Expect to Prescribe Gilead's Sofosbuvir/Ledipasvir Regimen Near-Term for Hepatitis C InfectionsHEADLINE2 Reimbursement and Out-of-Pocket Costs are the Leading Reasons for Treatment Discontinuation, According to Findings from Decision Resources GroupBURLINGTON, Mass., Aug. 19, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of hepatitis C virus (HCV) infections, 40 percent of surveyed HCV treating specialists expect to prescribe Gilead's investigational fixed-dose combination of sofosbuvir/ledipasvir in the next six months to…
  • Treating HCV- Learning The Basics

    19 Aug 2014 | 5:41 am
    HCV- Learning The BasicsHappy Tuesday folks, hope you all had a great weekend. Since a new week is just beginning why not try something new by using an online learning activity to gain additional knowledge about HCV?The HCV landscape is quickly changing, with many new investigational agents making their way to FDA approval, and newer treatments now available that require shorter treatment duration, less side effects and higher cure rates. In order to gain a better understand of treating HCV, a review of the basics, especially treatment response, is a necessary first step. By doing…
  • UK Says Sovaldi Is Worth It. We Should Listen.

    18 Aug 2014 | 12:18 pm
    UK Says Sovaldi Is Worth It. We Should Listen. Yevgeniy FeymanIt’s rare that I get to say this – but we can learn something from the United Kingdom. As our “free-market” health care system deliberates whether Gilead is charging a “just” price for its Hepatitis C (HCV) drug, Sovaldi, the UK’s National Institute for Health and Care Excellence (NICE) just approved the drug as being cost-effective, and recommended it for subgroups of patients...The battle over Sovaldi – which costs $84,000 in the U.S. for a full course of treatment – has sparked not only outrage from insurers…
  • How Do NS5A Inhibitors Prevent HCV Replication?

    18 Aug 2014 | 6:01 am
    How Do NS5A Inhibitors Prevent HCV Replication?Kristine NovakResearchers have uncovered the mechanisms of drugs that inhibit the hepatitis C virus (HCV) non-structural protein 5A (NS5A), described in the August issue of Gastroenterology. In a quantitative analysis of the kinetics of NS5A inhibitors, David R. McGivern et al. show that these agents rapidly inhibit intracellular assembly of virions and inhibit formation of functional replicase complexes, but have no activity against preformed replicase.NS5A inhibitors are likely to become an important component of hepatitis C treatment regimens,…
  • Updated - Debunking the Myths of Treating Hepatitis C

    17 Aug 2014 | 6:34 am
    Debunking the Myths of Treating Hepatitis C  08.05.14 | By Jennifer WallOriginal publish date was 7/21/2014; this post was updated on 8/5/2014.A national dialogue is needed around the value of new medicines and cures and the role they play in improving patient health and helping to manage long-term spending in the U.S. health care system.   Unfortunately, the debate around hepatitis C has, for the most part, been twisted to the point that modern-day cures are seen as a nuisance rather than a monumental step forward in the battle against disease.  For this reason, it…
 
Log in